Jan 282012
The RSS feed for this subscription is currently unavailable. Please try this subscription again later.
Jan 282012
The RSS feed for this subscription is currently unavailable. Please try this subscription again later.
Jan 282012
The RSS feed for this subscription is currently unavailable. Please try this subscription again later.
Jan 272012
The RSS feed for this subscription is currently unavailable. Please try this subscription again later.
Jan 272012
The RSS feed for this subscription is currently unavailable. Please try this subscription again later.
Jan 272012
The RSS feed for this subscription is currently unavailable. Please try this subscription again later.
Jan 272012
The RSS feed for this subscription is currently unavailable. Please try this subscription again later.
Jan 272012
The RSS feed for this subscription is currently unavailable. Please try this subscription again later.
Jan 272012
Roche, a leader in research-focused healthcare with combined strengths in pharmaceuticals, life science tools and diagnostics, announced today that it has commenced a cash tender offer to acquire all outstanding shares of Illumina, Inc. (NASDAQ: ILMN). The offer and withdrawal rights are scheduled to expire at 12:00 midnight, New York City time, at the end of the day on February 24, 2012, unless the offer is extended.
Jan 272012
The RSS feed for this subscription is currently unavailable. Please try this subscription again later.